Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gust H Bardy

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Heart Rhythm|October 31, 2012
Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trialsDemosthenes G Katritsis, Konstantinos C Siontis, J Thomas Bigger, et al.
Medicina (Kaunas, Lithuania)|April 30, 2021
Ventricular Fibrillation Recurrences in Successfully Shocked Out-of-Hospital Cardiac ArrestsDaniela Aschieri, Federico Guerra, Valentina Pelizzoni, et al.
American Heart Journal|June 2, 2007
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Brian Olshansky, Freda Wood, Anne S Hellkamp, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 20, 2012
Subcutaneous chronic implantable defibrillation systems in humansRiccardo Cappato, Warren M Smith, Margaret A Hood, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Heart Rhythm|October 31, 2012
Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trialsDemosthenes G Katritsis, Konstantinos C Siontis, J Thomas Bigger, et al.
Medicina (Kaunas, Lithuania)|April 30, 2021
Ventricular Fibrillation Recurrences in Successfully Shocked Out-of-Hospital Cardiac ArrestsDaniela Aschieri, Federico Guerra, Valentina Pelizzoni, et al.
American Heart Journal|June 2, 2007
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Brian Olshansky, Freda Wood, Anne S Hellkamp, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 20, 2012
Subcutaneous chronic implantable defibrillation systems in humansRiccardo Cappato, Warren M Smith, Margaret A Hood, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Pageof 7